Clinical trials
Brain Neoplasms trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 3 |
| 2011 | 2 |
| 2012 | 6 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 2 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Unknown status | 13 |
| Recruiting | 8 |
| Terminated | 5 |
| Active, not recruiting | 3 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Samsung Medical Center | 8 |
| Seoul National University Hospital | 8 |
| Yonsei University | 4 |
| AbbVie | 2 |
| AstraZeneca | 2 |
| Seoul National University Bundang Hospital | 2 |
| Alpha Biopharma (Jiangsu) Co., Ltd. | 1 |
| Asan Medical Center | 1 |
| Blueprint Medicines Corporation | 1 |
| Bristol-Myers Squibb | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brain Neoplasms | 52 |
| Carcinoma, Non-Small-Cell Lung | 11 |
| Breast Neoplasms | 8 |
| Glioblastoma | 6 |
| Neoplasms | 6 |
| Intracranial Aneurysm | 3 |
| Lung Neoplasms | 3 |
| Melanoma | 3 |
| Astrocytoma | 2 |
| Central Nervous System Neoplasms | 2 |
Trials
Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.